Cholera pp 329-349 | Cite as

Prevention and Control of Cholera

  • Dhiman Barua
  • Michael H. Merson
Part of the Current Topics in Infectious Disease book series (CTID)

Abstract

Chapter 1, on the history of the disease, concluded that the quirks of cholera are likely to continue to cause concern and despair as this pestiferous disease continues to menace much of the developing world, where at least 65% of the world’s population lives. Since 1991 Latin America has been affected and North America may be at risk. The word “cholera” still provokes considerable fear because, although measures exist for its prevention, control, and treatment, they are not available where they are most needed. Platitude or not, cholera continues to harass the developing world because of the underlying social and economic predicaments.

Keywords

Diarrheal Disease Refugee Camp Oral Rehydration Salt Cholera Outbreak Cholera Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pollitzer R: Cholera. Geneva, World Health Organization, 1959.Google Scholar
  2. 2.
    Liebermeister C: Cholera Asiatica and Cholera nostras, in Nothnagel H (ed): Spezielle Pathologie und Therapie, Wien, Vol 4, Part 1, 1896, p 1.Google Scholar
  3. 3.
    Howard-Jones N: The scientific background of the International Sanitary Conferences, 1851–1938.1 Who Chron 28: 159-179, 1974.Google Scholar
  4. 4.
    World Health Organization: International Health Regulations (1969), second annotated edition. Geneva, World Health Organization, 1974.Google Scholar
  5. 5.
    Baqui AH, Yunus M, Zaman K: Community-operated Treatment Centres prevented many cholera deaths. J Diar Dis Res 2: 92–98, 1984.Google Scholar
  6. 6.
    Faruque ASG, Eusof A, Islam ABMQ, et al: Community participation in a Diarrhoeal Outbreak: A Case Study. Trop Geogr Med 37: 216–222, 1985.PubMedGoogle Scholar
  7. 7.
    Mandara MP, Mhalu FS: Cholera in an inaccessible district in Tanzania: Importance of temporary rural centres. Med J Zambia 15: 10–13, 1980.-1981.PubMedGoogle Scholar
  8. 8.
    World Health Organization: Guidelines for Cholera Control WHO/CDD/SER 80.4 Rev.1, Geneva, 1986.Google Scholar
  9. 9.
    Assisting in Emergencies. A resource handbook for UNICEF field staff, New York, UNICEF, 1986.Google Scholar
  10. 10.
    Mhalu FS, Mtango FDE, Msengi AE: Hospital outbreaks of cholera transmitted through close person-to-person contact. Lancet ii: 82–84, 1984.CrossRefGoogle Scholar
  11. 11.
    Cliff JL, Zinkin P, Marteli A: A hospital outbreak of cholera in Maputo, Mozambique. R Soc Trop Med Hyg 80: 473–476, 1986.CrossRefGoogle Scholar
  12. 12.
    Grossman ER, Walchek A, Freedman H: Tetracycline and permanent teeth: The relation between dose and tooth colour. Pediatr 47: 567–570, 1971.Google Scholar
  13. 13.
    Stewart DT: Prevalence of tetracyclines in children’s teeth—Study II: A resurvey after 5 years. Br Med J 2: 320–322, 1973.CrossRefGoogle Scholar
  14. 14.
    Garrigue GP, Ndayo M, Sigard JM, et al: Resistance aux Antibiotique des Souches de Vibrio cholerae El Tor Isoléea à Douala (Cameroun). Bull Soc Pathol Exot Filiales 79: 305–312, 1986.PubMedGoogle Scholar
  15. 15.
    Bergoend H, Loffler A, Malville J: Reactions Cutanées Survennues au Cour de la Prophylaxie de Masse de la Meneingite Cerebrospinale par un Sulfamide Long-retard. Ann Dermatol 95: 481–490, 1968.Google Scholar
  16. 16.
    Hernborg A: Stevens Johnson syndrome after mass prophylaxis with sulphadoxine for cholera in Mozambique. Lancet ii: 1072–1073, 1985.CrossRefGoogle Scholar
  17. 17.
    Blake PA, Rosenberg ML, Costa JB, et al: Cholera in Portugal, 1974. 1. Modes of transmission. Am J Epidemiol 105: 337–343, 1977.PubMedGoogle Scholar
  18. 18.
    MacKenzie DJM: Cholera: Whither Prevention? Med Clin North Am 51: 625–635, 1967.PubMedGoogle Scholar
  19. 19.
    Gunn RA, Kimball AM, Matthew PP, et al: Cholera in Bahrain: Epidemiological characteristics of an outbreak. Bull WHO 59: 61–66, 1981.PubMedGoogle Scholar
  20. 20.
    Glass RI, Alim ARMA, Eusof A, et al: Cholera in Indonesia: Epidemiologic studies of transmission in Aceh province. Am J Trop Med Hyg 33: 933–939, 1984.PubMedGoogle Scholar
  21. 21.
    Moore BE, Perry L, Chard ST: A survey by the sewage swab method of latent enteric infections in an urban area. J Hyg (Lond) 50: 357–364, 1952.CrossRefGoogle Scholar
  22. 22.
    Barrett TJ, Blake PA, Morris GK, et al: Use of Moore Swabs for isolating Vibrio cholerae from sewage. J Clin Microbiol 11: 385–388, 1980.PubMedGoogle Scholar
  23. 23.
    Isaacson M: Practical aspects of cholera surveillance program. S Afr Med J 49: 1699–1702, 1975.PubMedGoogle Scholar
  24. 24.
    Kolvin JL, Roberts D: Studies on growth of Vibrio cholerae biotype El Tor and biotype classical in foods. J Hyg (Lond) 89: 243–252, 1982.CrossRefGoogle Scholar
  25. 25.
    Goh KT, Lam S, Ling MK: Epidemiological characteristics of an institutional outbreak of cholera. Trans R Soc Trop Med Hyg 81: 230–232, 1987.PubMedCrossRefGoogle Scholar
  26. 26.
    Felix H, Dodin A: Epidémiologie mondiale du choléra: Evolution entre 1970 et 1980. Bull Soc Pathol Exot Filiales 74: 17–30, 1981.PubMedGoogle Scholar
  27. 27.
    Stock RF: Cholera in Africa (African Environment Special Report 3). London, International African Institute, 1976.Google Scholar
  28. 28.
    Sitas F: Some observations on a cholera outbreak at the Umvoti Mission Reserve, Natal. S Afr Med J 70: 215–218, 1986.PubMedGoogle Scholar
  29. 29.
    Feachem RG: Environmental aspects of cholera epidemiology. III. Transmission and Control. Trop Dis Bull 79: 1–47, 1982.PubMedGoogle Scholar
  30. 30.
    Khan MU: Interruption of shigellosis by hand washing. Trans R Soc Trop Med Hyg 76: 164–168, 1982.PubMedCrossRefGoogle Scholar
  31. 31.
    Deb BC, Sircar BK, Sengupta PG, et al: Studies on interventions to prevent El Tor cholera transmission in urban slums. Bull WHO 64: 127–131, 1986.PubMedGoogle Scholar
  32. 32.
    Rajagopalan S, Shiffman MA: Guide to Simple Sanitary Measures for the Control of Enteric Diseases. Geneva, World Health Organization, 1974.Google Scholar
  33. 33.
    Technical Advisory Group, UNDP Interregional Project: Series of Publications on Water Supply and Sanitation. Washington, D.C., WUD Publications Group, The World Bank.Google Scholar
  34. 34.
    Khan MU, Khan MR, Hossain BR, et al: Alum potash in water to prevent cholera? Lancet ii: 1032, 1984.CrossRefGoogle Scholar
  35. 35.
    Clark RN: The purification of water on a small scale. Bull WHO 14: 820–826, 1956.PubMedGoogle Scholar
  36. 36.
    MacCormack WM, Chowhury AM, Jahangir M, et al: Tetracycline prophylaxis in families of cholera patients. Bull WHO 38: 787–792, 1968.Google Scholar
  37. 37.
    Joint ICMR-GWB-WHO Cholera Study Group: Effect of tetracycline on cholera carriers in households of cholera patients. Bull WHO 45: 451–455, 1971.Google Scholar
  38. 38.
    Lapeysonnie L: Chémioprophylaxie de l’infection cholérique: Interet, Espoirs et Limites. Méd Trop (Mars) 31: 127–132, 1971.Google Scholar
  39. 39.
    Deb BC, Sengupta PG, De SP, et al: Effect of sulfadoxine on transmission of Vibrio cholerae infection among family contacts of cholera patients in Calcutta. Bull WHO 54: 171–175, 1976.PubMedGoogle Scholar
  40. 40.
    Sengupta PC, Sircar BK, Mondai S, et al: Effect of doxycycline on transmission of Vibrio cholerae infection among family contacts of cholera patients in Calcutta. Bull WHO 56: 323–326, 1978.Google Scholar
  41. 41.
    Mhalu FS, Mmari PW, Ijumba J: Rapid emergence of El Tor Vibrio cholerae Resistant to antimicrobial agents during first 6 months of fourth cholera epidemic in Tanzania. Lancet i: 345–347, 1979.CrossRefGoogle Scholar
  42. 42.
    Joo I: Cholera vaccines, in Barua D, Burrows W (eds): Cholera. Philadelphia, WB Saunders, 1974, p 339.Google Scholar
  43. 43.
    Watanabe Y: Antibacterial immunity in cholera, in Barua D, Burrows W (eds): Cholera. Philadelphia, WB Saunders, 1974, p 298.Google Scholar
  44. 44.
    Mosley WH, Aziz KMA, Rahman ASMM, et al: Report of the 1966–67 cholera vaccine trial in rural East Pakistan. 4. Five years of observation with practical assessment of the role of a cholera vaccine in cholera control programmes. Bull WHO 47: 229–238, 1972.PubMedGoogle Scholar
  45. 45.
    Sommer A, Khan M. Mosley WH: Efficacy of vaccination of family contacts of cholera cases. Lancet i: 1230–1232, 1973.CrossRefGoogle Scholar
  46. 46.
    Sommer A, Mosley WH: Ineffectiveness of cholera vaccination as an epidemic control measure. Lancet i: 1232–1235, 1973.CrossRefGoogle Scholar
  47. 47.
    Steffen R: Epidemiologic studies of traveler’s diarrhea, severe gastrointestinal infections, and cholera. Rev Infect Dis 8 (Suppl 2):S122–S130, 1986.PubMedCrossRefGoogle Scholar
  48. 48.
    Snyder JD, Blake PA: Is cholera a problem for US travelers. JAMA 247: 2268–2269, 1982.CrossRefGoogle Scholar
  49. 49.
    Khan MU, Shahidullah M: Role of water and sanitation in the incidence of cholera in refugee camps. Trans R Soc Trop Med Hyg 76: 373–377, 1982.PubMedCrossRefGoogle Scholar
  50. 50.
    Morris JG, West GR, Hoick SE, et al: Cholera among refugees in Rangsit, Thailand. J Infect Dis 145: 131–133, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Dhiman Barua
  • Michael H. Merson

There are no affiliations available

Personalised recommendations